← Leaderboards
Lisa K Denzin
Sloan-Kettering Institute For Cancer Res
$4,897,432
Attributed
$4,897,432
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $589.8K · FY2005–16$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$4,897,432 · 5
By mechanism
R01$3,053,813 · 2
P30$969,848 · 1
R21$873,771 · 2
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Institute For Cancer Res
Same institution · by research overlap
- Riccardo Dalla-Favera$29,692,137
- Derek B. Sant'angelo$12,312,303
- Jerard Hurwitz$13,782,007
- John L Humm$4,845,995
- Alan N. Houghton$9,129,158
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsAntigensIn VivoProteinsPathway InteractionsAntigen PresentationMediatingAutoimmunityResearch StudyIn VitroT-LymphocyteModificationPlayComplexProductionHistocompatibility Antigens Class IiB LymphocyteB-LymphocytesImmune ResponsePeptidesInterestImmunizationMhc Class Ii AntigenLead
Grant awards (18)
Genetics identify HLA-DMB as a disease determinant for human type 1 diabetes$238,500
R21 · FY2016 · AI · contact PI
Genetics identify HLA-DMB as a disease determinant for human type 1 diabetes$198,750
R21 · FY2015 · AI · contact PI
The Molecular Mechanisms by which the Paf Oncogene Mediates Hematopoiesis$238,500
R21 · FY2014 · AI · contact PI
The Molecular Mechanisms by which the Paf Oncogene Mediates Hematopoiesis$119,949
R21 · FY2013 · AI · contact PI
The Molecular Mechanisms by which the Paf Oncogene Mediates Hematopoiesis$78,072
R21 · FY2013 · AI · contact PI
MONOCLONAL ANTIBODY$314,863
P30 · FY2011 · CA · contact PI
MONOCLONAL ANTIBODY$324,961
P30 · FY2010 · CA · contact PI
H2-O Mediated Antigen Focusing Modulates B Cell Immunity$424,620
R01 · FY2009 · AI · contact PI
MONOCLONAL ANTIBODY$165,147
P30 · FY2009 · CA · contact PI
H2-O Mediated Antigen Focusing Modulates B Cell Immunity$424,620
R01 · FY2008 · AI · contact PI
MONOCLONAL ANTIBODY$164,877
P30 · FY2008 · CA · contact PI
H2-O Mediated Antigen Focusing Modulates B Cell Immunity$432,844
R01 · FY2007 · AI · contact PI
H2-O Mediated Antigen Focusing Modulates B Cell Immunity$408,665
R01 · FY2006 · AI · contact PI
H2-O Mediated Antigen Focusing Modulates B Cell Immunity$418,500
R01 · FY2005 · AI
MODULATION OF CLASS II ANTIGEN PROCESSING BY HLA DO$246,712
R01 · FY2003 · AI
MODULATION OF CLASS II ANTIGEN PROCESSING BY HLA DO$239,526
R01 · FY2002 · AI
MODULATION OF CLASS II ANTIGEN PROCESSING BY HLA DO$232,550
R01 · FY2001 · AI
MODULATION OF CLASS II ANTIGEN PROCESSING BY HLA DO$225,776
R01 · FY2000 · AI